Obicetrapib Shows Promise for Heart Disease and Alzheimer's Prevention
Peter Attia explores a new CETP inhibitor that may reduce cardiovascular risk and protect against Alzheimer's disease in APOE4 carriers.
7 articles
Peter Attia explores a new CETP inhibitor that may reduce cardiovascular risk and protect against Alzheimer's disease in APOE4 carriers.
Peter Attia answers listener questions on cardiovascular risk, metabolic health, minimum-dose strength training, dementia prevention, and NAD supplements.
Simon Hill's cardiovascular masterclass covers the Portfolio Diet, plaque regression, ApoB testing, and the sodium-potassium ratio with top experts.
Dr. Terry Simpson brings personal experience with FH, tirzepatide, and statins to a blunt takedown of health misinformation.
Discover breathing techniques that lower blood pressure and adaptive medicine strategies for optimizing health naturally.
Dr. Benjamin Levine reveals the specific exercise protocol that can turn back the clock on cardiovascular aging by two decades.
Evidence-based training strategies for cardiovascular health, muscle strength, and longevity from leading exercise researchers.